Opioid Use Disorder Market Size, Share, Growth, and Industry Analysis, By Type (Buprenorphine, Methadone, Naltrexone), By Application (Moderate Pain Treatment, Severe Pain Treatment), Regional Insights and Forecast to 2035

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid Use Disorder Market Size 2019-2030
2.1.2 Opioid Use Disorder Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Opioid Use Disorder Segment by Type
2.2.1 Buprenorphine
2.2.2 Methadone
2.2.3 Naltrexone
2.3 Opioid Use Disorder Market Size by Type
2.3.1 Opioid Use Disorder Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Opioid Use Disorder Market Size Market Share by Type (2019-2024)
2.4 Opioid Use Disorder Segment by Application
2.4.1 Moderate Pain Treatment
2.4.2 Severe Pain Treatment
2.5 Opioid Use Disorder Market Size by Application
2.5.1 Opioid Use Disorder Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Opioid Use Disorder Market Size Market Share by Application (2019-2024)
3 Opioid Use Disorder Market Size by Player
3.1 Opioid Use Disorder Market Size Market Share by Players
3.1.1 Global Opioid Use Disorder Revenue by Players (2019-2024)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Use Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Opioid Use Disorder by Regions
4.1 Opioid Use Disorder Market Size by Regions (2019-2024)
4.2 Americas Opioid Use Disorder Market Size Growth (2019-2024)
4.3 APAC Opioid Use Disorder Market Size Growth (2019-2024)
4.4 Europe Opioid Use Disorder Market Size Growth (2019-2024)
4.5 Middle East & Africa Opioid Use Disorder Market Size Growth (2019-2024)
5 Americas
5.1 Americas Opioid Use Disorder Market Size by Country (2019-2024)
5.2 Americas Opioid Use Disorder Market Size by Type (2019-2024)
5.3 Americas Opioid Use Disorder Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Use Disorder Market Size by Region (2019-2024)
6.2 APAC Opioid Use Disorder Market Size by Type (2019-2024)
6.3 APAC Opioid Use Disorder Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Opioid Use Disorder by Country (2019-2024)
7.2 Europe Opioid Use Disorder Market Size by Type (2019-2024)
7.3 Europe Opioid Use Disorder Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid Use Disorder by Region (2019-2024)
8.2 Middle East & Africa Opioid Use Disorder Market Size by Type (2019-2024)
8.3 Middle East & Africa Opioid Use Disorder Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Opioid Use Disorder Market Forecast
10.1 Global Opioid Use Disorder Forecast by Regions (2025-2030)
10.1.1 Global Opioid Use Disorder Forecast by Regions (2025-2030)
10.1.2 Americas Opioid Use Disorder Forecast
10.1.3 APAC Opioid Use Disorder Forecast
10.1.4 Europe Opioid Use Disorder Forecast
10.1.5 Middle East & Africa Opioid Use Disorder Forecast
10.2 Americas Opioid Use Disorder Forecast by Country (2025-2030)
10.2.1 United States Opioid Use Disorder Market Forecast
10.2.2 Canada Opioid Use Disorder Market Forecast
10.2.3 Mexico Opioid Use Disorder Market Forecast
10.2.4 Brazil Opioid Use Disorder Market Forecast
10.3 APAC Opioid Use Disorder Forecast by Region (2025-2030)
10.3.1 China Opioid Use Disorder Market Forecast
10.3.2 Japan Opioid Use Disorder Market Forecast
10.3.3 Korea Opioid Use Disorder Market Forecast
10.3.4 Southeast Asia Opioid Use Disorder Market Forecast
10.3.5 India Opioid Use Disorder Market Forecast
10.3.6 Australia Opioid Use Disorder Market Forecast
10.4 Europe Opioid Use Disorder Forecast by Country (2025-2030)
10.4.1 Germany Opioid Use Disorder Market Forecast
10.4.2 France Opioid Use Disorder Market Forecast
10.4.3 UK Opioid Use Disorder Market Forecast
10.4.4 Italy Opioid Use Disorder Market Forecast
10.4.5 Russia Opioid Use Disorder Market Forecast
10.5 Middle East & Africa Opioid Use Disorder Forecast by Region (2025-2030)
10.5.1 Egypt Opioid Use Disorder Market Forecast
10.5.2 South Africa Opioid Use Disorder Market Forecast
10.5.3 Israel Opioid Use Disorder Market Forecast
10.5.4 Turkey Opioid Use Disorder Market Forecast
10.5.5 GCC Countries Opioid Use Disorder Market Forecast
10.6 Global Opioid Use Disorder Forecast by Type (2025-2030)
10.7 Global Opioid Use Disorder Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Indivior
11.1.1 Indivior Company Information
11.1.2 Indivior Opioid Use Disorder Product Offered
11.1.3 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Indivior Main Business Overview
11.1.5 Indivior Latest Developments
11.2 Alkermes
11.2.1 Alkermes Company Information
11.2.2 Alkermes Opioid Use Disorder Product Offered
11.2.3 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alkermes Main Business Overview
11.2.5 Alkermes Latest Developments
11.3 Titan Pharmaceuticals
11.3.1 Titan Pharmaceuticals Company Information
11.3.2 Titan Pharmaceuticals Opioid Use Disorder Product Offered
11.3.3 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Titan Pharmaceuticals Main Business Overview
11.3.5 Titan Pharmaceuticals Latest Developments
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Information
11.4.2 Hikma Pharmaceuticals Opioid Use Disorder Product Offered
11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Hikma Pharmaceuticals Main Business Overview
11.4.5 Hikma Pharmaceuticals Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Opioid Use Disorder Product Offered
11.5.3 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 MediciNova
11.6.1 MediciNova Company Information
11.6.2 MediciNova Opioid Use Disorder Product Offered
11.6.3 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 MediciNova Main Business Overview
11.6.5 MediciNova Latest Developments
11.7 Orexo
11.7.1 Orexo Company Information
11.7.2 Orexo Opioid Use Disorder Product Offered
11.7.3 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Orexo Main Business Overview
11.7.5 Orexo Latest Developments
11.8 Camurus
11.8.1 Camurus Company Information
11.8.2 Camurus Opioid Use Disorder Product Offered
11.8.3 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Camurus Main Business Overview
11.8.5 Camurus Latest Developments
11.9 Omeros
11.9.1 Omeros Company Information
11.9.2 Omeros Opioid Use Disorder Product Offered
11.9.3 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Omeros Main Business Overview
11.9.5 Omeros Latest Developments
12 Research Findings and Conclusion